Publications by authors named "Helene Dreyfus"

Claim this Profile
L
Letrozole to prevent breast cancer in postmenopausal women with BRCA1/2 mutations (LIBER study).
Pascal Pujol, Lise Roca, Alain Lortholary, Christine Lasset, Louise Crivelli, Hélène Dreyfus

Eur J Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening Mammography and Breast Cancer: Variation in Risk with Rare Deleterious or Predicted Deleterious Variants in DNA Repair Genes.
Maximiliano Ribeiro-Guerra, Marie-Gabrielle Dondon, Séverine Eon-Marchais, Dorothée Le Gal, Juana Beauvallet, Hélène Dreyfus

Cancers (Basel)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Intragenic Duplication Combined with a Likely Pathogenic Variant in a Patient with Triple-Negative Breast Cancer: Clinical Risk and Management.
Vuthy Ea, Claudine Berthozat, Hélène Dreyfus, Clémentine Legrand, Estelle Rousselet

Int J Mol Sci· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Squamous Cell Carcinoma of the Lung With Microsatellite Instability in a Patient With Lynch Syndrome: A Case Report.
Emna Haddad, Benjamin Bottet, Pierre-Alain Thiebaut, Samira Morin, Hélène Dreyfus

JTO Clin Res Rep· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association and performance of polygenic risk scores for breast cancer among French women presenting or not a familial predisposition to the disease.
Yue Jiao, Thérèse Truong, Séverine Eon-Marchais, Noura Mebirouk, Sandrine M Caputo, Hélène Dreyfus

Eur J Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach.
Sandrine M Caputo, Lisa Golmard, Mélanie Léone, Francesca Damiola, Marine Guillaud-Bataille, Helene Dreyfus

Am J Hum Genet· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational analysis of apoptotic genes in familial aggregation of hematological malignancies.
Walid Sabri Hamadou, Rahma Mani, Nouha Bouali, Sawsen Besbes, Violaine Bourdon, Hélène Dreyfus

Bull Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutation.
Maximiliano Ribeiro Guerra, Juliette Coignard, Séverine Eon-Marchais, Marie-Gabrielle Dondon, Dorothée Le Gal, Hélène Dreyfus

Breast Cancer Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TUMOSPEC: A Nation-Wide Study of Hereditary Breast and Ovarian Cancer Families with a Predicted Pathogenic Variant Identified through Multigene Panel Testing.
Fabienne Lesueur, Séverine Eon-Marchais, Sarah Bonnet-Boissinot, Juana Beauvallet, Marie-Gabrielle Dondon, Hélène Dreyfus

Cancers (Basel)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene- and pathway-level analyses of iCOGS variants highlight novel signaling pathways underlying familial breast cancer susceptibility.
Christine Lonjou, Séverine Eon-Marchais, Thérèse Truong, Marie-Gabrielle Dondon, Mojgan Karimi, Hélène Dreyfus

Int J Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing.
Elodie Girard, Séverine Eon-Marchais, Robert Olaso, Anne-Laure Renault, Francesca Damiola, Hélène Dreyfus

Int J Cancer· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GATA2 gene analysis in several forms of hematological malignancies including familial aggregations.
Walid Sabri Hamadou, Rahma Mani, Sawsen Besbes, Violaine Bourdon, Yosra Ben Youssef, Hélène Dreyfus

Ann Hematol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ARLTS1, potential candidate gene in familial aggregation of hematological malignancies.
Walid Sabri Hamadou, Sawsen Besbes, Rahma Mani, Violaine Bourdon, Yosra Ben Youssef, Hélène Dreyfus

Bull Cancer· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Familial hematological malignancies: new IDH2 mutation.
Walid-Sabri Hamadou, Violaine Bourdon, Sébastien Létard, Fabienne Brenet, Sofien Laarif, Hélène Dreyfus

Ann Hematol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The genomic architecture of NLRP7 is Alu rich and predisposes to disease-associated large deletions.
Ramesh Reddy, Ngoc M P Nguyen, Guillaume Sarrabay, Maryam Rezaei, Mayra C G Rivas, Hélène Dreyfus

Eur J Hum Genet· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The genomic architecture of NLRP7 is Alu rich and predisposes to disease-associated large deletions.
Ramesh Reddy, Ngoc M P Nguyen, Guillaume Sarrabay, Maryam Rezaei, Mayra C G Rivas, Hélène Dreyfus

Eur J Hum Genet· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational analysis of JAK2, CBL, RUNX1, and NPM1 genes in familial aggregation of hematological malignancies.
Walid S Hamadou, Violaine Bourdon, Pascaline Gaildrat, Sawsen Besbes, Aurélie Fabre, Hélène Dreyfus

Ann Hematol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GENESIS: a French national resource to study the missing heritability of breast cancer.
Olga M Sinilnikova, Marie-Gabrielle Dondon, Séverine Eon-Marchais, Francesca Damiola, Laure Barjhoux, Hélène Dreyfus

BMC Cancer· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers.
Sophie Blein, Claire Bardel, Vincent Danjean, Lesley McGuffog, Sue Healey, Hélène Dreyfus

Breast Cancer Res· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of BRCA1 germ-line mutation status in patients with breast cancer using histoprognosis grade, MS110, Lys27H3, vimentin, and KI67.
Mohamed Hassanein, Laetitia Huiart, Violaine Bourdon, Laetitia Rabayrol, Jeanine Geneix, Helene Dreyfus

Pathobiology· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers.
Yuan C Ding, Lesley McGuffog, Sue Healey, Eitan Friedman, Yael Laitman, Hélène Dreyfus

Cancer Epidemiol Biomarkers Prev· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial.
Pascal Pujol, Christine Lasset, Pascaline Berthet, Catherine Dugast, Suzette Delaloge, Helene Dreyfus

Fam Cancer· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular study of the perforin gene in familial hematological malignancies.
Rim El Abed, Violaine Bourdon, Ilia Voskoboinik, Halima Omri, Yosra Ben Youssef, Hélène Dreyfus

Hered Cancer Clin Pract· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers.
Amanda B Spurdle, Louise Marquart, Lesley McGuffog, Sue Healey, Olga Sinilnikova, Hélène Dreyfus

Cancer Epidemiol Biomarkers Prev· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.
Antonis C Antoniou, Jonathan Beesley, Lesley McGuffog, Olga M Sinilnikova, Sue Healey, Hélène Dreyfus

Cancer Res· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis